Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

NVOH vs. SCHF: which is better?

Bottom line

NVOH vs SCHF: the short answer

NVOH (Novo Nordisk A/S (B Shares) ADRhedged) and SCHF (Schwab International Equity ETF) are both etfs.

But SCHF is far broader, holding 1,479 positions to 3 for NVOH, so beyond the top names it adds exposure NVOH doesn't have.

SCHF is cheaper at 0.03% vs 0.19% — a difference of $16 a year per $10,000 invested.

Updated Nov 19, 2026

NVOH vs SCHF side by side

NVOHSCHF
TypeETFETF
Fund familyDWS (Xtrackers)Schwab
CategoryInternational StockInternational Stock
Expense ratio0.19%0.03%
Annual cost per $10k$19$3
10-yr cost on $10k (prospectus)$243$39
Max front loadNoneNone
12b-1 fee0%—
1-yr return—+3.5%
5-yr return (annualized)—+5.0%
10-yr return (annualized)—+5.4%
Best quarter—+17.0%
Worst quarter—−23.1%
Net assets (fund)$4.2M$66.5B
Number of holdings31,479
Portfolio turnover%4%
Returns as of—Dec 31, 2024

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

NVOH and SCHF share none of their top holdings.

NVOH top 10

  1. Novo Nordisk A/s — 96.87%
  2. Dreyfus Trsry Securities — 2.79%
  3. Canadian Imperial Bank Of Commerce — -0.08%

SCHF top 10

  1. Samsung Electronics Co Ltd — 3.32%
  2. SK hynix Inc — 2.81%
  3. ASML Holding NV — 2.10%
  4. HSBC Holdings PLC — 1.08%
  5. Roche Holding AG — 0.99%
  6. Novartis AG — 0.97%
  7. AstraZeneca PLC — 0.93%
  8. Royal Bank of Canada — 0.90%
  9. Nestle SA — 0.88%
  10. Shell PLC — 0.80%

FAQ

What is the difference between NVOH and SCHF?
NVOH (Novo Nordisk A/S (B Shares) ADRhedged) and SCHF (Schwab International Equity ETF) are both etfs. But SCHF is far broader, holding 1,479 positions to 3 for NVOH, so beyond the top names it adds exposure NVOH doesn't have.
Which is cheaper, NVOH or SCHF?
SCHF has the lower expense ratio (0.03%).
Should I own both NVOH and SCHF?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.